• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Mackenzie's Mission HomepageMackenzie's Mission

DONATE Mackenzies Mission Donate
  • Mission
  • About
    • The Story
    • Board
  • Resources
    • Resource List
    • What Is Amyloidosis
  • Speakers Bureau
    • About ASB
    • ASB Operating Committee
  • Fundraisers
  • Blog
  • Contact

Hereditary Amyloidosis

A Patient Guide for Understanding Amyloidosis

July 25, 2023

Amyloidosis is a multi-system disease, making diagnosis challenging. In this informative patient guide, the American Society of Nuclear Cardiology (ASNC) discusses common symptoms, types of amyloidosis, red flags to be aware of, diagnostic tests and available treatment options.

Filed Under: Featured News, What Is Amyloidosis Tagged With: AL amyloidosis, Amyloid cardiomyopathy, amyloidosis, amyloidosis diagnosis, ATTR amyloidosis, ATTR-CA, ATTR-CM, attrv, ATTRwt, cardiac amyloidosis, diagnosing amyloidosis, hATTR, Hereditary Amyloidosis, light chain amyloidosis, wild-type amyloidosis

Multidisciplinary Care for Cardiac Amyloidosis Patients

June 24, 2023

Multi-systemic diseases such as amyloidosis are not only complex to diagnose, but also complex in the treatment and ongoing patient care. It takes a village. In this seminal piece, the American College of Cardiology (ACC) provides an Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis. An absolute must-read for cardiologists and other specialties such as neurology, gastroenterology, nephrology and hematology.

Filed Under: Featured News, What Is Amyloidosis Tagged With: AL amyloidosis, Amyloid cardiomyopathy, amyloidosis, amyloidosis treatment, ATTR amyloidosis, ATTR-CM, attrv, ATTRwt, cardiac amyloidosis, cardiology, gastroenterology, hATTR, heart failure, hematology, Hereditary Amyloidosis, light chain amyloidosis, nephrology, neurology, wild-type amyloidosis

Hereditary Amyloidosis: The V122I Variant

March 30, 2023

Despite the evidence that a meaningful 3-4% of the US Black population of West African ancestry likely carries the V122I genetic mutation, hereditary TTR amyloidosis remains significantly underdiagnosed and undertreated in this population. Amyloidosis can be devastating to both patients and their families. Increased awareness of the disease, availability of testing, and FDA-approved therapies are slowly beginning to shift this dynamic. However, there is still much work to be done to close the gap between diagnosed cases and the population estimated to be affected.

Filed Under: Featured News Tagged With: Amyloid cardiomyopathy, amyloidosis, amyloidosis diagnosis, ATTR amyloidosis, attrv, hATTR, hATTR-CM, heart failure, Hereditary Amyloidosis

Hereditary Amyloidosis: The T60A Variant

February 23, 2023

Hereditary transthyretin amyloidosis is caused by a genetic mutation which causes misfolding of transthyretin (TTR) proteins (which originate from the liver). There are over 100 genetic variants of hereditary amyloidosis. One such variant, called T60A, is the most common variant in Ireland (and the UK).

Filed Under: Featured News Tagged With: amyloidosis, ATTR amyloidosis, attrv, hATTR, Hereditary Amyloidosis, Irish Variant, T60A

Worldwide Hotspots of Hereditary ATTR Amyloidosis (ATTRv)

January 26, 2023

Transthyretin Amyloidosis, or ATTR, is considered a single disease, however the diversity in its clinical presentation is staggering. In this blog, we’ll discuss some of the most common hereditary variants and how the disease manifestation differs around the world in documented hotspots.

Filed Under: Featured News, What Is Amyloidosis Tagged With: amyloidosis, amyloidosis variants, ATTR amyloidosis, attrv, global amyloidosis, hATTR, Hereditary Amyloidosis, worldwide amyloidosis

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

Recent News

  • Inflation Reduction Act of 2022 & Amyloidosis
  • A Patient Guide for Understanding Amyloidosis
  • Multidisciplinary Care for Cardiac Amyloidosis Patients
  • ATTR-CM: Don’t Assume it’s Wild-Type TTR Amyloidosis
  • Helping Patients Find Their Voice

Be A Part Of Our Mission!

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

  • Mission
  • About
  • Resources
  • Speakers Bureau
  • Fundraisers
  • Blog
  • Contact

Registered 501(c)(3) · Contact · Copyright © 2023 · Mackenzies Mission - All Rights Reserved